Cambridge Consultants, a technology product design and development firm, today announced its novel pre-filled syringe concept ‘Syreen.’ A revolutionary ‘green’ syringe design, Syreen is effective, safe, and easy-to-use drug delivery device for self administration use, designed to ease the resource intensity and material wastage associated with traditional syringe development and manufacture.
Instead of glass, Syreen syringes are made with cyclic olefin polymer (COP) plastic, which has enabled Cambridge Consultants to shed the need for secondary packaging. The makeup of the Syreen allows syringes to clip together, nesting in a pack while the COP design doubles as the outer shell of the packaging itself. The Syreen eliminates the need for wasteful fillers such as cardboard and styrofoam, reducing the packaging weight by 30% and volume by 50% from today’s standard packaging. The US alone produces 6,600 tons of medical waste per day, equaling well over two million tons per year—approximately 85% of which goes to landfills throughout the country.
“What makes Syreen so exciting is that while it is a sustainable alternative to the status quo, it can truly introduce a paradigm shift in the existing supply chain,” said Phil Lever, Commercial Director, Drug Delivery Devices for Cambridge Consultants. “We found that typical glass syringes use many materials from all over the world and that shipping costs are egregious due to inefficiencies in packaging. This marriage of economy and ecology shows that medical device companies will likely see competitive benefits by taking sustainability seriously.”
Cambridge Consultants is currently seeking to develop the Syreen concept with large pharmaceutical and pharmaceutical packaging companies.